ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,972Medicare Part D Prescriptions Filled, Including Refills

Rank: 58 out of 355

$483K Total Retail Price of All Prescriptions

Rank: 80 out of 355

383 Patients Receiving at Least One Drug in Part D
83% Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Rhode Island
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

4% of this provider’s 383 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

11% of this provider’s 383 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $47 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
METOPROLOL TARTRATE 656 563 86 1 8
ATORVASTATIN CALCIUM 627 539 91 2 4
SIMVASTATIN 591 455 78 3 3
FUROSEMIDE 475 441 77 4 7
OMEPRAZOLE 430 368 62 5 5
LISINOPRIL 389 317 63 6 1
AMLODIPINE BESYLATE 385 385 50 7 2
LEVOTHYROXINE SODIUM 361 318 49 8 6
HYDROCODONE-ACETAMINOPHEN 297 219 41 S3 9 17
METOPROLOL SUCCINATE 219 214* 29 10 20
LISINOPRIL-HYDROCHLOROTHIAZIDE 197 192* 27 11 38
METFORMIN HCL 189 164 29 12 12
DOXAZOSIN MESYLATE 176 176 22 13 68
ATENOLOL 174 174 22 14 11
LORAZEPAM 171 147 32 B 15 30
GLYBURIDE 158 125 30 R 16 75
SERTRALINE HCL 153 110 22 17 15
CLOPIDOGREL 153 148* 22 17 22
LOVASTATIN 143 138* 22 19 27
WARFARIN SODIUM 121 105 23 20 10
GLIPIZIDE 120 115* 17 21 47
RANITIDINE HCL 120 100 22 21 36
HYDROCHLOROTHIAZIDE 120 101 28 21 9
TRAMADOL HCL 117 74 25 24 31
TAMSULOSIN HCL 107 90 17 25 26
ALENDRONATE SODIUM 100 95* 13 26 23
ALPRAZOLAM 97 76 20 B 27 21
ISOSORBIDE MONONITRATE ER 91 91 11 28 74
CLONAZEPAM 90 55 15 B 29 39
QUINAPRIL HCL 90 72 14 29 63
PROAIR HFA 89 68 21 31 40
LOSARTAN-HYDROCHLOROTHIAZIDE 87 72 14 32 55
CARVEDILOL 84 <11 <11 33 67
ALLOPURINOL 81 76* 13 34 29
TRAZODONE HCL 78 65 13 35 16
LOSARTAN POTASSIUM 77 <11 <11 36 13
GLYBURIDE-METFORMIN HCL 76 63 14 R 37 146
CRESTOR 74 <11 <11 38 34
IBUPROFEN 73 68* 21 39 65
PRAVASTATIN SODIUM 73 62 17 39 14
LANTUS SOLOSTAR 71 <11 <11 41 128
TRAMADOL HCL-ACETAMINOPHEN 71 66* 19 41 177
ENALAPRIL MALEATE 69 <11 <11 43 49
SYNTHROID 69 <11 <11 43 43
KLOR-CON M20 66 <11 <11 45 69
PREDNISONE 66 61* 17 45 41
CITALOPRAM HBR 66 52 11 45 18
FLUOXETINE HCL 61 <11 <11 48 59
DIOVAN 61 <11 <11 48 37
EVISTA 58 <11 <11 50 119
GABAPENTIN 58 53* 11 50 19
HYDRALAZINE HCL 57 52* 12 52 123
NEXIUM 57 <11 <11 52 60
ZOLPIDEM TARTRATE 56 <11 <11 54 28
FLUTICASONE PROPIONATE 50 45* 17 55 35
SPIRIVA 50 <11 <11 55 42
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.